Prophylactic Pregabalin to Decrease Pain During Medical Abortion
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Medical abortion has been associated with significant pain. The objective of this trial is to
determine whether one dose of pregabalin 300 mg, given during medical abortion in addition to
the standard of care analgesics, will decrease experienced pain. Investigators will perform a
randomized, double-blinded, placebo-controlled trial. Participant pain levels and side
effects will be assessed at multiple time points, along with a measure of satisfaction.